Amy M. Spiegel
AbbVie (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neuroscience and Neuropharmacology Research, Memory and Neural Mechanisms, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → Hilar interneuron vulnerability distinguishes aged rats with memory impairment(2013)130 cited
- → Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study(2023)93 cited
- → Aging reduces total neuron number in the dorsal component of the rodent prefrontal cortex(2011)58 cited
- → Epigenetic contributions to cognitive aging: disentangling mindspan and lifespan(2014)38 cited
- → Age‐associated changes in hippocampal‐dependent cognition in Diversity Outbred mice(2014)36 cited
- → Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance(2024)31 cited
- → Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa(2024)17 cited
- → Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease(2025)5 cited
- → Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study(2023)1 cited
- → P4‐276: Age‐Dependent Hippocampal Changes in OCTODON DEGUS(2016)1 cited